Ovid Therapeutics Inc Earnings

The next earnings date for Ovid Therapeutics Inc is November 12, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Ovid Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/12/2025	$-0.14

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Ovid Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/13/2025	---	$-0.06	62.50%
05/12/2025	Before Market	$-0.14	33.33%
03/06/2025	Before Market	$-0.13	22.20%
11/01/2024	Before Market	$-0.20	1.35%
08/02/2024	Before Market	$0.12	154.55%
05/14/2024	Before Market	$-0.17	22.73%
03/08/2024	Before Market	$-0.22	-340.00%
11/03/2023	Before Market	$-0.16	15.79%
08/04/2023	Before Market	$-0.18	10.00%
05/05/2023	Before Market	$-0.19	-11.76%
03/13/2023	Before Market	$-0.16	11.11%
11/08/2022	Before Market	$-0.17	19.05%
08/09/2022	Before Market	$-0.21	16.00%
05/10/2022	Before Market	$-0.23	-9.52%
03/15/2022	Before Market	$-0.10	37.50%
11/10/2021	Before Market	$-0.17	5.56%
08/16/2021	Before Market	$-0.23	-43.75%
05/13/2021	After Market	$2.53	50.60%
03/15/2021	Before Market	$-0.34	-9.68%
11/12/2020	After Market	$-0.28	22.22%
08/10/2020	Before Market	$-0.41	-13.89%
05/07/2020	Before Market	$-0.37	-12.12%
03/11/2020	Before Market	$-0.35	14.63%
11/08/2019	Before Market	$-0.43	-19.44%
08/07/2019	After Market	$-0.34	20.93%
05/07/2019	Before Market	$-0.46	-9.52%
03/07/2019	After Market	$-0.52	5.45%
11/08/2018	Before Market	$-0.53	11.67%
08/09/2018	After Market	$-0.53	11.67%
05/15/2018	Before Market	$-0.54	-3.85%
03/29/2018	After Market	$-0.45	-9.76%
11/09/2017	After Market	$-0.38	29.63%
08/10/2017	After Market	$-0.57	-21.28%
06/13/2017	After Market	$-3.48	-300.00%

More About Ovid Therapeutics Inc

Website

https://www.ovidrx.com

Country

USA

Full Time Employees

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

“Ovid Therapeutics Inc Earnings” Can Refer to the Ovid Therapeutics Inc Earnings Date

Some people say “Ovid Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Ovid Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Ovid Therapeutics Inc Stock on the Earnings Date

If you own Ovid Therapeutics Inc stock (OVID) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Ovid Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Ovid Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Ovid Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Ovid Therapeutics Inc earnings or anything else related to the stock market.